Cargando…
Risk factors for adverse drug reactions associated with clopidogrel therapy
This study aimed to investigate the possible influence of genetic and non-genetic factors on the incidence of clopidogrel adverse drug reactions (ADRs) in cardiology patients, including the most important CYP2C19 alleles, namely *2 and *17, as well as compliance, dose, drug interactions, and clinica...
Autores principales: | Mugosa, Snezana, Radosavljevic, Ivan, Sahman, Majda, Djordjevic, Natasa, Todorovic, Zoran |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
De Gruyter
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8990878/ https://www.ncbi.nlm.nih.gov/pubmed/35480401 http://dx.doi.org/10.1515/med-2021-0371 |
Ejemplares similares
-
ABCB1 polymorphism in clopidogrel-treated Montenegrin patients
por: Mugosa, Snezana, et al.
Publicado: (2021) -
Adverse drug reactions and polypharmacy in cardiac patients
por: Mugoša, Snežana, et al.
Publicado: (2012) -
Factors affecting the development of adverse drug reactions to β-blockers in hospitalized cardiac patient population
por: Mugoša, Snežana, et al.
Publicado: (2016) -
Utilization of Mycophenolic Acid, Azathioprine, Tacrolimus, Cyclosporin, Sirolimus, and Everolimus: Multinational Study
por: Sahman, Majda, et al.
Publicado: (2021) -
Profile of rheumatology patients willing to report adverse drug reactions: bias from selective reporting
por: Protić, Dragana, et al.
Publicado: (2016)